Treatment targets in patients with type 2 diabetes set by primary care physicians from Central and Eastern Europe

REFERENCES

• Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The fifth joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Atherosclerosis 2012;223:1–68.
   PubMed Web of Science ®Google Scholar
• Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28:88–136.
   PubMed Web of Science ®Google Scholar
• Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: Executive summary: Fourth joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375–414.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Diabet Med. 2008;25:1151–6.
   PubMed Web of Science ®Google Scholar
• Stone MA, Wilkinson JC, Charpentier G, Clochard N, Grassi G, Lindblad U, et al.; GUIDANCE Study Group. Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries. Diabetes Res Clin Pract. 2010;87:252–60.
   PubMed Web of Science ®Google Scholar
• Chatzikyrkou C, Haller H, Menne J. Therapeutic targets in arterial hypertension and diabetes mellitus. Can medical prevention be harmful?Internist (Berl) 2012;53:882–92. (In German.)
   PubMed Web of Science ®Google Scholar
• , Action to Control Cardiovascular Risk in Diabetes Study GroupGerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.
   PubMed Web of Science ®Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, et al. Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. Blood Press 2009;18:308–47.
   PubMed Web of Science ®Google Scholar
• , ACCORD Study GroupCushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362: 1575–85.
   PubMed Web of Science ®Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycaemia in type 2 diabetes: A patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2012;55:1577–96.
   PubMed Web of Science ®Google Scholar
• Fabian W, Majkowska L, Stefański A, Moleda P. (Diabetes control in type 2 diabetic subjects treated in primary health care—how far is from life to standards?). Przegl Lek 2008; 65:277–82. (In Polish.)
   Google Scholar
• Tomasik T, Windak A, Jozwiak J, Oleszczyk M, Seifert B, Kersnik J, et al. Treatment of hypertension in Central and Eastern European countries: Self-reported practice of primary care physicians. J Hypertens. 2012;30:1671–8.
   Google Scholar
• Tomasik T, Windak A, Seifert B, Kersnik J, Palka M, Margas G, et al. The self-perceived role of general practitioners in care of patients with cardiovascular diseases. A survey in Central and Eastern European countries following health care reforms. Int J Cardiol. 2013;164:327–33.
   PubMed Web of Science ®Google Scholar
• Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: Blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:2281–6.
   PubMed Web of Science ®Google Scholar
• Seifert B, Švab I, Madis I, Kersnik J, Windak A, Steflova A, et al. Perspectives of family medicine in Central and Eastern Europe. Fam Pract. 2008;25:113–8.
   PubMed Web of Science ®Google Scholar
• Reiner Z, Sonicki Z, Tedeschi-Reiner E. Physicians’ perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: The PERCRO-DOC survey. Atherosclerosis 2010;213:598–603.
   PubMed Web of Science ®Google Scholar
• Stewart J, Kendrick D; Nottingham Diabetes Blood Pressure Study Group. Setting and negotiating targets in people with type 2 diabetes in primary care: A cross sectional survey. Diabet Med. 2005;22:683–7.
   PubMed Web of Science ®Google Scholar
• Chalmers J, Arima H, Harrap S, Touyz RM, Park JB. Global survey of current practice in management of hypertension as reported by societies affiliated with the international society of hypertension. J Hypertens. 2013;31:1043–8.
   PubMed Web of Science ®Google Scholar
• McCrate F, Godwin M, Murphy L. Attainment of Canadian Diabetes Association recommended targets in patients with type 2 diabetes: A study of primary care practices in St John's, Nfld. Can Fam Physician 2010;56:e13–9.
   PubMed Web of Science ®Google Scholar
• Woo V, Shestakova MV, Ørskov C, Ceriello A. Targets and tactics: The relative importance of HbA, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes. Int J Clin Pract. 2008;62:1935–42.
   PubMed Web of Science ®Google Scholar
• Akalin S, Berntorp K, Ceriello A, Das AK, Kilpatrick ES, Koblik T, et al. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control. Int J Clin Pract. 2009;63:1421–5.
   PubMed Web of Science ®Google Scholar
• Klemenc-Ketis Z, Kersnik J. The assessment of pharmaceutical sales representatives by family physicians—does it affect the prescribing index?Fam Pract. 2013;30:320–4.
   Google Scholar
• Allen J, Gay B, Crebolder H, Heyrman J, Svab I, Ram P. The European definitions of the key features of the discipline of general practice: The role of the GP and core competencies. Br J Gen Pract. 2002;52:526–7.
   PubMed Web of Science ®Google Scholar
• Koshizaka M, Green JB, Alexander JH. Glycemic management in diabetes and the associated cardiovascular risk: Are we helping or hurting our patients?Circ J. 2012;76:1572–80.
   Google Scholar
• Nau DP. Recommendations for improving adherence to type 2 diabetes mellitus therapy—focus on optimizing oral and non-insulin therapies. Am J Manag Care 2012;18:S49–54.
   PubMedGoogle Scholar
• Vyshka G, Kruja J. Inapplicability of advance directives in a paternalistic setting: The case of a post-communist health system. BMC Med Ethics 2011;12:12.
   Google Scholar
• Rätsep A, Kalda R, Lember M. Meeting targets in type 2 diabetes care contributing to good glycaemic control. A cross-sectional study from a primary care setting in Estonia. Eur J Gen Pract. 2010;16:85–91.
   PubMed Web of Science ®Google Scholar